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Dermatological Therapy by Topical
Application of Non-Pathogenic
Bacteria
Teruaki Nakatsuji1 and Richard L. Gallo1
The microbial community inhabiting skin is an important part of its defense, acting
to control immune responses and to influence susceptibility to pathogens. In
this issue, Volz et al. report that Vitreoscilla filiformis extracts modulate mouse
cutaneous inflammatory responses induces of interleukin-10 production in
dendritic cells and priming of regulatory T cells. These findings in a mouse model
of atopic dermatitis advance observations of links between bacteria and host
immunity, and they provide further evidence for novel therapeutic strategies to
treat inflammation in skin.
Journal of Investigative Dermatology (2014) 134, 11–14. doi:10.1038/jid.2013.379
Microbial mutualism
Mammalian skin is colonized by with
diverse microbial communities (Grice
et al., 2009; Nakatsuji et al., 2013).
Knowledge of these associations is
based on observations that skin pro-
vides environmental niches in which
such organisms survive, whereas at the
same time symbiotically providing
functioning to maintain skin health.
Several recent studies have provided
details regarding the mechanisms by
which bacterial products from com-
mensal bacteria modulate host immu-
nity, thus advancing, at least in part, the
‘‘pseudo-science’’ label formerly assig-
ned to claims of benefits from undefined
biological potions. Although at one time
the scientific community considered
bacterial products only to stimulate
inflammation, we now know that some
products can suppress inflammation as
well. For example, we demonstrated
that lipoteichoic acid produced by the
human skin commensal bacterium
Staphylococcus epidermidis (S. epider-
midis) suppresses skin inflammation
from injury through a Toll-like receptor 2
(TLR2)-dependent mechanism (Lai et al.,
2009). More recently, skin commensal
bacteria have been shown to provide
benefit by enhancing cutaneous
T-cell functions via activation of
interleukin (IL)-1 signaling (Naik et al.,
2012). Indeed, mono-colonization of
germ-free mouse skin by S. epidermidis
protected these mice against pathogen
infection in comparison to germ-free
skin (Naik et al., 2012). Commensal
skin microbes such as S. epidermidis
also provide benefit by producing
natural antimicrobial substances that
aid in resisting pathogens (Cogen et al.,
2010). In total, the actions of
commensal skin bacteria support
the hypothesis that a mutually bene-
ficial relationship exists between
microbes and human skin (Gallo and
Nakatsuji, 2011; Table 1). In this issue,
Volz et al. (2013) report that products
of a non-pathogenic bacterium, V. fili-
formis, has the capacity to suppress
atopic dermatitis (AD)-like inflamma-
tion in mice. These findings also
support the concept that we are on the
verge of a new age of skin therapies,
exploiting knowledge of the function of
microbial communities and redefining
what should considered ‘‘self’’ and
‘‘non-self.’’
Dysbiosis and AD
The concept of a mutualistic beneficial
relationship between surface bacteria
and skin is supported further by obser-
vations concerning disruption of this
interaction. For example, AD is a classic
inflammatory skin disorder that has long
been known to be associated with dys-
biosis (a state of microbial imbalance)
of the surface microbial community
(Leyden et al., 1974). These early
observations have been repeated and
extended with modern 16S sequencing
approaches (Kong et al., 2012). So far,
however, clear evidence for a cause and
effect relationship between AD and
microbial dysbiosis has remained
elusive. Thus, the relationship between
disease and dysbiosis remains an
attractive hypothesis awaiting experi-
mental proof.
AD is a complex, multifactorial dis-
order with several genetic risk factors
but major environmental triggers. Patients
exhibit alterations in T-cell homeostasis,
suppression of cathelicidin and b-defen-
sin antimicrobial responses, and physi-
cal barrier defects (Ong et al., 2002;
Kupper and Fuhlbrigge, 2004; Palmer
et al., 2006). The combination of phy-
sical barrier and antimicrobial barrier
defects likely drives the microbial
dysbiosis, which disrupts further the
balance of cellular immunity necessary
to establish inflammatory equilibrium
with the external environment. Regula-
tory T (Treg) cells are crucial mediators
of the balance between tolerance to
antigens (both ‘‘self’’ and foreign) and
immune responses. The secretion of
anti-inflammatory cytokines, such as
IL-10, is one mechanism by which this
balance is achieved (Sakaguchi et al.,
2010). Although it remains controversial
whether defects in Treg cells contribute
to the pathogenesis of AD, depletion
of FoxP3þ Treg cells in mice drives
AD-like symptoms such as expression
of Th2 cytokines and elevated serum
IgE (Fyhrquist et al., 2012). Because of
the recognized associations between
products of bacteria and Treg cell func-
tion, AD provides an ideal model system
to appreciate the potential benefits of a
‘‘normal’’ microbiome.
See related article on pg 96
1Division of Dermatology, Department of Medicine, University of California, San Diego, San Diego,
California, USA
Correspondence: Richard L. Gallo, Division of Dermatology, Department of Medicine, University of
California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0869, USA.
E-mail: rgallo@ucsd.edu
COMMENTARY
www.jidonline.org 11
Treg respond to bacteria
For the intestinal microenvironment,
investigators have identified molecular
mechanisms by which bacteria (or their
metabolites) affect Treg responses. Den-
dritic cells (DCs) are a central regulator
and mediator of naı¨ve T-cell differentia-
tion to pro- and anti-inflammatory
CD4þ T helper cells by distinguishing
commensal bacteria from pathogens
(Manicassamy et al., 2010). Polysaccha-
ride A (PSA), a unique surface polysac-
charide from the commensal bacterium
Bacteroides fragilis in the human gut, is
taken up and presented by DC. These
PSA-presenting DCs prime naive CD4þ
T cells, which undergo differentiation to
FoxP3þ Treg cells under the influence
of transforming growth factor-b and
retinoic acids produced by the DCs
(Round and Mazmanian, 2010). In
addition, PSA binds directly to TLR2
on FoxP3þ Treg cells, and it induces
IL-10 production (Round et al., 2011).
Colonization by some strains of indige-
nous Clostridium species in the mouse
intestinal tract also promotes accumu-
lation of FoxP3þ Treg cells through
enhanced expression of matrix metal-
loproteinases by intestinal epithelial
cells, which are involved in the activa-
tion of latent transforming growth factor-
b complexes (Atarashi et al., 2011).
More recently, it has been demonstra-
ted that short-chain free fatty acids,
fermentation metabolites of dietary
fiber by intestinal commensal micro-
biota, increase the frequency and
number of Foxp3þ Treg cells in the
large intestine through binding to
G-protein coupled receptor 43 (Smith
et al., 2013). Because free fatty acids are
also predominant components in human
sebum, such a Treg response may be
involved in maintaining inflammatory
homeostasis in skin. Overall, current
data suggest that hosts and microbes
communicate in many different ways
to arrive at a similar end point,
inflammatory homeostasis. However,
the immune mechanisms in skin that
manipulate inflammation in general, or
Treg cell function in particular, remain
poorly understood.
Exploiting the therapeutic potential of
bacteria
The beneficial activities of commensal
bacteria in immune homeostasis have
led to several therapeutic strategies that
seek to target inflammatory and auto-
immune diseases, especially for inflam-
matory bowel disease. For example, it
has been demonstrated recently that
transplantation of reconstruction of a
healthy intestinal microbial ecosystem
from purified bacterial cultures obtained
from stool of healthy donors (RePOO-
Pulate) is capable of curing colitis
induced by antibiotic-resistant Clostri-
dium difficile infection (Petrof et al.,
2013). In addition, transplantation of a
Table 1. Anti-inflammatory signaling stimulated by non-pathogenic bacteria
Ligand/organism
Cellular
element/target
cell Downstream signal Biological significance Reference
PSA from Bacteroides fragilis DCs Induce FoxP3þ Treg cell
differentiation
Acquire tolerance to own microbiota and maintain
intestinal inflammatory homeostasis
Round and
Mazmanian
(2010)
PSA from B. fragilis TLR-2/FoxP3þ
Treg cell
Stimulate IL-10 production Acquire tolerance to own microbiota and maintain
intestinal inflammatory homeostasis
Round et al.
(2011)
Commensal Clostridium
species
Intestinal
epithelial cell
Induction of FoxP3þ Treg through
MMP induction
Acquire tolerance to own microbiota and maintain
intestinal inflammatory homeostasis
Atarashi et al.
(2013)
Short-chain FFAs/intestinal
microbiota
GPR43/
neutrophil
Suppress chemoattraction of
neutrophils
Regulate systemic inflammation and immune
homeostasis
Maslowski et al.
(2009)
Short-chain FFAs/intestinal
microbiota
GPR43/FoxP3þ
Treg cell
Maturation and proliferation of
Treg cells
Acquire tolerance to own microbiota and maintain
intestinal inflammatory homeostasis
Smith et al.
(2013)
LTA from
Stapphylococcus epidermidis
TLR2/
keratinocytes
Suppress TLR-3-mediated
inflammation
Control inflammation during skin wound healing Lai et al. (2009)
Lactobacillus salivarius and
Bifidobacterium breve
Mechanisms
unknown
Increase ratio of Treg to Th17 cells
and rescue Th2 skewing
Oral probiotic therapy for atopic dermatitis Iemoli et al.
(2012)
Vitreoscilla filiformis from
spa water
TLR2/DCs Induce IL-10þ DCs and stimulate
differentiation of Tr1 cells
Topical therapy for inflammatory skin disorders Volz et al. (2013)
Abbreviations: DC, dendritic cell; FFA, free-fatty acid; GPR43, G-protein coupled receptor 43; IL, interleukin; LTA, lipopolysaccharide; MMP, matrix
metalloproteinase; PSA, polysaccharide A; Th, T helper cell; TLR, Toll-like receptor 4; Treg, regulatory T cell.
Clinical Implications
 Epicutaneous application of a lysate of a bacterium found in thermal spas
(Vitreoscilla filiformis) suppresses inflammation in mice.
 V. filiformis lysates induce Toll-like receptor 2-dependent production
of interleukin-10 (IL-10) from dendritic cells and prime regulatory
T cells.
 Targeted production of IL-10 by non-pathogenic bacteria is a promising
approach to topical anti-inflammatory therapy.
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mixture of commensal Clostridium
species isolated from a healthy human
fecal samples successfully induced the
accumulation and functional maturation
of Treg cells in the colon, resulting in
attenuation of disease in mouse models
of colitis and allergic diarrhea (Atarashi
et al., 2013). Oral probiotic treatment,
which presumably would effect the gut
microbiome, increased the frequency
of FoxP3þ Treg cells in skin draining
lymph nodes in a murine model of
cutaneous allergy, and it decreased
inflammation, as well (Hacini-Rachinel
et al., 2009). Thus, the intestinal micro-
biome may also influence the skin.
In a human study, oral treatment with
a combination of probiotics strains
(Lactobacillus salivarius and Bifidobac-
terium breve) for 3 months significantly
improved ratio of Th17/Treg cells in
peripheral blood of adult AD patient as
well as decreasing the severity of skin
inflammation (Iemoli et al., 2012). These
observations suggest a link between the
intestinal microenvironment and skin
health, a topic of controversy in the
management of AD (Boyle et al.,
2009). Part of this controversy may
stem from different activities of the
probiotic strains that were employed
and a lack of molecular mechanistic
detail concerning the observations.
Treg cells hit the spa
Volz et al., now shows that epicuta-
neous administration of a lysate of
V. filiformis beneficially modulates the
local skin immunity, adding important
mechanistic insight into these processes.
Notably, the signal of V. filiformis was
transmitted successfully to cells below
the skin surface, an observation at odds
with classic concepts about the tight
barrier properties of epidermis, but con-
sistent with our recent observations that
influences from the microbiome pene-
trate into the dermis and exist in equili-
brium across an epidermal barrier
(Nakatsuji et al., 2013).
V. filiformis is a gram-negative
bacterium originally found in thermal
spa water. Because V. filiformis is
thought to contribute to the beneficial
effect of spa water, a bacterial lysate of
V. filiformis has been used informally
as dermatological treatment (Gueniche
et al., 2008). Indeed, clinical studies
have demonstrated that a topical formu-
lation of V. filiformis lysate significantly
improved AD and seborrheic dermatitis
in comparison to placebo treatment
(Gueniche et al., 2006; Gueniche
et al., 2008). In this issue, Volz et al.
(2013) take these observations a step
further by suggesting that the anti-
inflammatory effect of V. filiformis is
by activating cutaneous Treg cells. They
show a lysate of V. filiformis induces
maturation of IL-10þ DCs. V. filiformis-
induced DC maturation was indepen-
dent of MyD88, an essential mediator
for signal transduction by TLR2 and
IL-1R, whereas production of IL-10 was
decreased greatly in the absence of
MyD88 or TLR2. Thus, V. filiformis can
trigger maturation of DC by multiple
pathways, but requires TLR2 for IL-10
production. It remains unclear whether
TLR1 or TLR6, which act in complex
with TLR2, is required for this pathway.
V. filiformis-induced IL-10þ DCs primed
naive CD4þ T cells, resulting in
differentiation to IFN-glow IL-10high type
1 Treg (Tr1) cells, an inducible subset of
Treg cells, but one lacking FoxP3
expression. This observation was relevant
functionally as the authors demonstrated
that epicutaneous application with
V. filiformis lysate induced IL-10high
T cells and inhibited antigen-specific
T-cell proliferation during AD-like
inflammation in NC/Nga mice. Thus,
V. filiformis lysate from a spa exerted
an effect similar to PSA extracted from
B. fragilis isolated from the gut. The
manipulation of Treg cells or IL-10-
producing DCs by V. filiformis lysate
may not only hold promise for treating
AD, but also other skin inflammatory
diseases. Expect to see much more from
this field in the near future.
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Hippo: Hungry, Hungry for Melanoma
Invasion
Ileine M. Sanchez1 and Andrew E. Aplin1
The acquisition of invasive properties in melanoma is associated with a high
proclivity for metastasis, but the underlying pathways are poorly characterized.
The Hippo pathway has an important role in organ size control and is
dysregulated in some type of tumors. The present study, ‘‘Pro-invasive activity
of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma’’ by Nallet-
Staub et al., 2013, provides the first in-depth analysis of expression of the Hippo
pathway effectors YAP (yes-associated protein) and TAZ (Tafazzin) in human
melanocytic lesions. Importantly, results from this study demonstrate a causal
relationship between YAP/TAZ levels and melanoma cell tumorigenicity and
invasiveness.
Journal of Investigative Dermatology (2014) 134, 14–16. doi:10.1038/jid.2013.372
The Salvador/Warts/Hippo signaling
pathway, here simply referred to as the
Hippo pathway, is an evolutionarily
conserved regulator of organ size and
tumorigenesis (Harvey et al., 2013). The
hpo gene was originally identified
in Drosophila melanogaster. Its loss
resulted in mutant fruit fly heads
bearing overgrown cuticles with dark
folds (Udan et al., 2003). It was this
hippopotamus head-like appearance for
which the gene and the pathway were
named (Udan et al., 2003). Activation of
the pathway induces the interaction of a
core cassette of serine/threonine kinases
and adaptors that cascade to result in
the phosphorylation of effector mole-
cules, YAP and TAZ (Harvey et al.,
2013; Figure 1). These core components
include the serine/threonine kinases
MST1/2 (hpo homologs) and LATS 1/2
and the adaptor proteins MOB1 and
SAV1 (Harvey et al., 2013). The loss of
other pathway components pheno-
copies the overgrowth seen in hpo
mutants through effects on both cell pro-
liferation and apoptosis (Justice et al.,
1995; Jia et al., 2003; Udan et al.,
2003). The pathway terminal kinases,
LATS1/2, phosphorylate transcriptional
See related article on pg 123
co-activator YAP to regulate trans-
cription of proliferative and apoptotic
factors (Harvey et al., 2013). Whereas
unphosphorylated YAP translocates to
the nucleus and interacts with TEAD
family transcription factors, LATS
1/2-phosphorylated YAP is rendered
inactive via cytoplasmic sequestration
by 14-3-3 proteins (Zhao et al., 2007).
TAZ, a YAP paralog, shares 50% sequ-
ence identity with YAP, and also
interacts with the TEAD family trans-
cription factors (Lei et al., 2008). This
interaction is prevented by phosphory-
lation and sequestration in a similar
manner to YAP (Lei et al., 2008). Thus,
YAP/TAZ phosphorylation and locali-
zation can be used as markers for
Hippo signaling. Owing to its aforemen-
tioned role in cell growth, the Hippo
pathway has been investigated in
tumorigenesis, using various cancer
types (Harvey et al., 2013). YAP
expression is amplified in colonic
adenocarcinoma, lung adenocarci-
noma, ovarian serous cystadenocarci-
noma, and ductal carcinoma of the
breast (Steinhardt et al., 2008). Cuta-
neous melanoma is well-known for its
invasive and metastatic behavior;
however, the role of Hippo signaling
in this disease remains poorly chara-
cterized. In this highlighted article,
Nallet-Staub et al. (2013) show a link
between Hippo pathway effectors and
melanoma invasion and colony forma-
tion in vitro and in vivo.
Nallet-Staub et al. (2013) analyzed
YAP and TAZ expression in melanoma
cell lines and melanocytic lesions.
While TAZ expression was elevated
in melanoma cell lines compared
with normal human melanocytes, these
levels were variable, and no diffe-
rences in YAP1/2 expression were
noted. Furthermore, immunohistoche-
mical analyses showed no differences
in YAP and TAZ staining between
benign nevi and superficial spreading
melanoma. Thus, YAP and TAZ do not
represent biomarker candidates for
melanoma invasion. However, the data
does support a causal relationship
between Hippo signaling and mela-
noma invasive properties. YAP and
TAZ knockdown in melanoma lines
with high basal YAP/TAZ levels inhi-
bited in vitro tumorigenicity, Matrigel
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